amifostine anhydrous has been researched along with phosphorus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attie, MF; Fallon, MD; Goldfarb, S; Slatopolsky, E; Spar, B; Wolf, JS | 1 |
Chaney, SG; Holbrook, DJ; Thompson, DC; Wyrick, SD | 1 |
Blasig, IE; Haseloff, R; Jänichen, F; Keller, T; Krause, EG; Pissarek, M; Tapp, E | 1 |
3 other study(ies) available for amifostine anhydrous and phosphorus
Article | Year |
---|---|
Bone and parathyroid inhibitory effects of S-2(3-aminopropylamino)ethylphosphorothioic acid. Studies in experimental animals and cultured bone cells.
Topics: Amifostine; Animals; Bone and Bones; Bone Resorption; Calcium; Calcium Radioisotopes; Cells, Cultured; Dogs; Male; Organothiophosphorus Compounds; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Inbred Strains | 1985 |
HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
Topics: Amifostine; Antineoplastic Agents; Chromatography, High Pressure Liquid; Magnetic Resonance Spectroscopy; Organoplatinum Compounds; Phosphorus; Radiation-Protective Agents | 1995 |
Cardioprotective potency of the radical scavenger S-2-(3 aminopropylamino) ethylphosphorothioic acid in the post-ischaemic rat heart.
Topics: Amifostine; Animals; Electron Spin Resonance Spectroscopy; Energy Metabolism; Free Radical Scavengers; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Myocardial Reperfusion Injury; Phosphorus; Rats; Rats, Wistar | 1995 |